Skip to main content
. 2022 Mar 10;12:858276. doi: 10.3389/fonc.2022.858276

Table 4.

Outcome of patients during their ICU stay.

No cancer (n = 315) Cancer patients (n = 105) Hematological maligancies (n = 51) Solid tumors (n = 54)
ARDS, Berlin definition 224 (71·1%) 81 (77·1%) 42 (82·4%) 39 (72·2%)
Superficial thrombosis 6 (1·9%) 2 (1·9%) 0 (0%) 2 (3·7%)
Deep thrombosis 24 (7·6%) 5 (4·8%) 3 (5·9%) 2 (3·7%)
Pulmonary embolism 21 (6·7%) 4 (3·8%) 4 (7·8%) 0 (0%)
ICU-acquired pneumonia 117 (37·1%) 47 (44·8%) 26 (51·0%) 21 (38·9%)
Arterial ischemia 1 (0·3%) 2 (1·9%) 0 (0%) 2 (3·7%)
Ancocoagulation therapy-related bleeding 20 (6·3%) 10 (9·5%) 6 (11·8%) 4 (7·4%)
ICU death at day 60 86 (27·4%) 59 (56·2%) 30 (58·8%) 29 (53·7%)
Main cause of ICU death
 Refractory hypoxemia 20 (23·3%) 13 (22·0%) 8 (26·7%) 5 (17·2%)
 Withholding and withdrawing of  lifesustaining therapies 24 (27·9%) 24 (40·7%) 14 (46·7%) 10 (34·5%)
 Multiple organ failure 32 (37·2%) 17 (28·8%) 6 (20·0%) 11 (37·9%)
 Pulmonary embolism 0 (0%) 1 (1·7%) 1 (3·3%) 0 (0%)
 Arterial ischemia 0 (0%) 2 (3·4%) 0 (0%) 2 (6·9%)
 ICU-acquired pneumonia 0 (0%) 1 (1·7%) 1 (3·3%) 0 (0%)
 Others 6 (7·0%) 1 (1·7%) 0 (0%) 1 (3·4%)

ARDS, Acute respiratory distress syndrome; ICU, intensive care unit.